nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—forelimb—amyotrophic lateral sclerosis	0.0315	0.145	CbGeAlD
Lisinopril—ACE—hindlimb—amyotrophic lateral sclerosis	0.0283	0.13	CbGeAlD
Lisinopril—ACE—arm—amyotrophic lateral sclerosis	0.027	0.124	CbGeAlD
Lisinopril—ACE—appendage—amyotrophic lateral sclerosis	0.0243	0.112	CbGeAlD
Lisinopril—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0234	0.0299	CcSEcCtD
Lisinopril—ACE—peripheral nervous system—amyotrophic lateral sclerosis	0.0221	0.102	CbGeAlD
Lisinopril—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0235	CcSEcCtD
Lisinopril—ACE—nerve—amyotrophic lateral sclerosis	0.0172	0.0793	CbGeAlD
Lisinopril—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0216	CcSEcCtD
Lisinopril—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.015	0.0191	CcSEcCtD
Lisinopril—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0181	CcSEcCtD
Lisinopril—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0158	CcSEcCtD
Lisinopril—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.012	0.0154	CcSEcCtD
Lisinopril—ACE2—nervous system—amyotrophic lateral sclerosis	0.0118	0.0545	CbGeAlD
Lisinopril—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0149	CcSEcCtD
Lisinopril—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0149	CcSEcCtD
Lisinopril—ACE2—central nervous system—amyotrophic lateral sclerosis	0.0114	0.0525	CbGeAlD
Lisinopril—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0137	CcSEcCtD
Lisinopril—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0102	0.013	CcSEcCtD
Lisinopril—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0129	CcSEcCtD
Lisinopril—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00986	0.0126	CcSEcCtD
Lisinopril—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00979	0.0125	CcSEcCtD
Lisinopril—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00973	0.0124	CcSEcCtD
Lisinopril—Gout—Riluzole—amyotrophic lateral sclerosis	0.00954	0.0122	CcSEcCtD
Lisinopril—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0121	CcSEcCtD
Lisinopril—ACE2—brain—amyotrophic lateral sclerosis	0.00906	0.0417	CbGeAlD
Lisinopril—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00901	0.0115	CcSEcCtD
Lisinopril—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00891	0.0114	CcSEcCtD
Lisinopril—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00891	0.0114	CcSEcCtD
Lisinopril—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00846	0.0108	CcSEcCtD
Lisinopril—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00836	0.0107	CcSEcCtD
Lisinopril—ACE—embryo—amyotrophic lateral sclerosis	0.00807	0.0371	CbGeAlD
Lisinopril—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00793	0.0101	CcSEcCtD
Lisinopril—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00781	0.00997	CcSEcCtD
Lisinopril—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00743	0.0095	CcSEcCtD
Lisinopril—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0074	0.00945	CcSEcCtD
Lisinopril—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00736	0.00941	CcSEcCtD
Lisinopril—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00719	0.00919	CcSEcCtD
Lisinopril—Injury—Riluzole—amyotrophic lateral sclerosis	0.00703	0.00899	CcSEcCtD
Lisinopril—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00891	CcSEcCtD
Lisinopril—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00682	0.00872	CcSEcCtD
Lisinopril—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00853	CcSEcCtD
Lisinopril—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00665	0.0085	CcSEcCtD
Lisinopril—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00649	0.00829	CcSEcCtD
Lisinopril—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00647	0.00826	CcSEcCtD
Lisinopril—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00647	0.00826	CcSEcCtD
Lisinopril—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00641	0.00819	CcSEcCtD
Lisinopril—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00797	CcSEcCtD
Lisinopril—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00615	0.00785	CcSEcCtD
Lisinopril—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00777	CcSEcCtD
Lisinopril—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00601	0.00768	CcSEcCtD
Lisinopril—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0059	0.00754	CcSEcCtD
Lisinopril—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00746	CcSEcCtD
Lisinopril—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00731	CcSEcCtD
Lisinopril—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00714	CcSEcCtD
Lisinopril—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00714	CcSEcCtD
Lisinopril—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00548	0.007	CcSEcCtD
Lisinopril—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00695	CcSEcCtD
Lisinopril—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00537	0.00687	CcSEcCtD
Lisinopril—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00531	0.00678	CcSEcCtD
Lisinopril—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00668	CcSEcCtD
Lisinopril—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00668	CcSEcCtD
Lisinopril—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00658	CcSEcCtD
Lisinopril—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00652	CcSEcCtD
Lisinopril—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00509	0.0065	CcSEcCtD
Lisinopril—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00646	CcSEcCtD
Lisinopril—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0064	CcSEcCtD
Lisinopril—Depression—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00635	CcSEcCtD
Lisinopril—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00628	CcSEcCtD
Lisinopril—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00624	CcSEcCtD
Lisinopril—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00624	CcSEcCtD
Lisinopril—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0062	CcSEcCtD
Lisinopril—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00619	CcSEcCtD
Lisinopril—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0061	CcSEcCtD
Lisinopril—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00607	CcSEcCtD
Lisinopril—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00602	CcSEcCtD
Lisinopril—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0047	0.006	CcSEcCtD
Lisinopril—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00597	CcSEcCtD
Lisinopril—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00594	CcSEcCtD
Lisinopril—ACE—spinal cord—amyotrophic lateral sclerosis	0.0046	0.0212	CbGeAlD
Lisinopril—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00582	CcSEcCtD
Lisinopril—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00573	CcSEcCtD
Lisinopril—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00571	CcSEcCtD
Lisinopril—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00569	CcSEcCtD
Lisinopril—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00567	CcSEcCtD
Lisinopril—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00564	CcSEcCtD
Lisinopril—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00563	CcSEcCtD
Lisinopril—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0056	CcSEcCtD
Lisinopril—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0054	CcSEcCtD
Lisinopril—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00518	CcSEcCtD
Lisinopril—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00515	CcSEcCtD
Lisinopril—Chills—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00513	CcSEcCtD
Lisinopril—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.004	0.0051	CcSEcCtD
Lisinopril—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00505	CcSEcCtD
Lisinopril—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00501	CcSEcCtD
Lisinopril—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00497	CcSEcCtD
Lisinopril—ACE—nervous system—amyotrophic lateral sclerosis	0.00387	0.0178	CbGeAlD
Lisinopril—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00384	0.0049	CcSEcCtD
Lisinopril—Tension—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00488	CcSEcCtD
Lisinopril—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00487	CcSEcCtD
Lisinopril—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00483	CcSEcCtD
Lisinopril—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00481	CcSEcCtD
Lisinopril—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00478	CcSEcCtD
Lisinopril—ACE—central nervous system—amyotrophic lateral sclerosis	0.00373	0.0172	CbGeAlD
Lisinopril—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00466	CcSEcCtD
Lisinopril—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00462	CcSEcCtD
Lisinopril—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0046	CcSEcCtD
Lisinopril—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00455	CcSEcCtD
Lisinopril—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00449	CcSEcCtD
Lisinopril—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00447	CcSEcCtD
Lisinopril—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00446	CcSEcCtD
Lisinopril—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00445	CcSEcCtD
Lisinopril—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00344	0.0044	CcSEcCtD
Lisinopril—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00437	CcSEcCtD
Lisinopril—Cough—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00434	CcSEcCtD
Lisinopril—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00424	CcSEcCtD
Lisinopril—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00424	CcSEcCtD
Lisinopril—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00424	CcSEcCtD
Lisinopril—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00422	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00421	CcSEcCtD
Lisinopril—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00418	CcSEcCtD
Lisinopril—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00414	CcSEcCtD
Lisinopril—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00409	CcSEcCtD
Lisinopril—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00406	CcSEcCtD
Lisinopril—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00406	CcSEcCtD
Lisinopril—Infection—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00403	CcSEcCtD
Lisinopril—Shock—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00399	CcSEcCtD
Lisinopril—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00397	CcSEcCtD
Lisinopril—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00396	CcSEcCtD
Lisinopril—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00394	CcSEcCtD
Lisinopril—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00392	CcSEcCtD
Lisinopril—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00387	CcSEcCtD
Lisinopril—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00379	CcSEcCtD
Lisinopril—ACE—brain—amyotrophic lateral sclerosis	0.00296	0.0136	CbGeAlD
Lisinopril—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0037	CcSEcCtD
Lisinopril—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00367	CcSEcCtD
Lisinopril—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00365	CcSEcCtD
Lisinopril—ABCB1—embryo—amyotrophic lateral sclerosis	0.00284	0.0131	CbGeAlD
Lisinopril—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00362	CcSEcCtD
Lisinopril—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00361	CcSEcCtD
Lisinopril—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00357	CcSEcCtD
Lisinopril—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00353	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0035	CcSEcCtD
Lisinopril—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0035	CcSEcCtD
Lisinopril—Pain—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00347	CcSEcCtD
Lisinopril—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00347	CcSEcCtD
Lisinopril—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00335	CcSEcCtD
Lisinopril—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00332	CcSEcCtD
Lisinopril—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00323	CcSEcCtD
Lisinopril—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00321	CcSEcCtD
Lisinopril—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00321	CcSEcCtD
Lisinopril—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00299	CcSEcCtD
Lisinopril—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00291	CcSEcCtD
Lisinopril—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00287	CcSEcCtD
Lisinopril—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00278	CcSEcCtD
Lisinopril—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00268	CcSEcCtD
Lisinopril—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00258	CcSEcCtD
Lisinopril—Rash—Riluzole—amyotrophic lateral sclerosis	0.002	0.00256	CcSEcCtD
Lisinopril—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.002	0.00256	CcSEcCtD
Lisinopril—Headache—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00254	CcSEcCtD
Lisinopril—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00241	CcSEcCtD
Lisinopril—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00181	0.00835	CbGeAlD
Lisinopril—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00162	0.00745	CbGeAlD
Lisinopril—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00136	0.00628	CbGeAlD
Lisinopril—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00131	0.00604	CbGeAlD
Lisinopril—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00128	0.00591	CbGeAlD
Lisinopril—ABCB1—brain—amyotrophic lateral sclerosis	0.00104	0.0048	CbGeAlD
